PENNSYLVANIA
|
|
No.
23-0993790
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer
Identification
No.)
|
Exhibit
No.
|
|
99.1
|
Press
Release of Quaker Chemical Corporation dated October 28, 2008.
|
QUAKER
CHEMICAL CORPORATION
Registrant
|
||
Date:
October 29, 2008
|
By:
|
/s/
Mark A. Featherstone
|
Mark
A. Featherstone
Vice
President and
Chief
Financial Officer
|
NEWS
|
||
For
Release:
Immediate
|
Contact:
Mark
A. Featherstone
Vice
President and
Chief
Financial Officer
610-832-4160
|
|
|
(Unaudited)
|
|||||||||||||
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Net
sales
|
$
|
159,506
|
$
|
140,715
|
$
|
465,412
|
$
|
403,204
|
|||||
Cost
of goods sold
|
112,981
|
97,547
|
330,466
|
278,878
|
|||||||||
Gross
margin
|
46,525
|
43,168
|
134,946
|
124,326
|
|||||||||
%
|
29.2
|
%
|
30.7
|
%
|
29.0
|
%
|
30.8
|
%
|
|||||
Selling,
general and administrative expenses
|
38,278
|
36,602
|
109,935
|
103,930
|
|||||||||
CEO
transition costs
|
1,625
|
-
|
3,505
|
-
|
|||||||||
Environmental
charges
|
-
|
3,300
|
-
|
3,300
|
|||||||||
Operating
income
|
6,622
|
3,266
|
21,506
|
17,096
|
|||||||||
%
|
4.2
|
%
|
2.3
|
%
|
4.6
|
%
|
4.2
|
%
|
|||||
Other
income, net
|
(96
|
)
|
382
|
1,752
|
1,618
|
||||||||
Interest
expense, net
|
(1,044
|
)
|
(1,370
|
)
|
(3,205
|
)
|
(4,221
|
)
|
|||||
Income
before taxes
|
5,482
|
2,278
|
20,053
|
14,493
|
|||||||||
Taxes
on income
|
967
|
(1,066
|
)
|
5,848
|
3,076
|
||||||||
4,515
|
3,344
|
14,205
|
11,417
|
||||||||||
Equity
in net income of associated companies
|
191
|
166
|
490
|
557
|
|||||||||
Minority
interest in net income of subsidiaries
|
(266
|
)
|
(350
|
)
|
(841
|
)
|
(1,126
|
)
|
|||||
Net
income
|
$
|
4,440
|
$
|
3,160
|
$
|
13,854
|
$
|
10,848
|
|||||
%
|
2.8
|
%
|
2.2
|
%
|
3.0
|
%
|
2.7
|
%
|
|||||
Per
share data:
|
|||||||||||||
Net
income - basic
|
$
|
0.42
|
$
|
0.32
|
$
|
1.34
|
$
|
1.09
|
|||||
Net
income - diluted
|
$
|
0.41
|
$
|
0.31
|
$
|
1.31
|
$
|
1.07
|
|||||
Shares
Outstanding:
|
|||||||||||||
Basic
|
10,573,497
|
10,016,801
|
10,315,769
|
9,969,739
|
|||||||||
Diluted
|
10,796,716
|
10,134,909
|
10,544,070
|
10,095,945
|
(Unaudited)
|
|||||||
September 30,
|
December 31,
|
||||||
2008
|
2007
|
||||||
ASSETS
|
|||||||
Current
assets
|
|||||||
Cash
and cash equivalents
|
$
|
24,066
|
$
|
20,195
|
|||
Construction
fund (restricted cash)
|
9,325
|
-
|
|||||
Accounts
receivable, net
|
119,538
|
118,135
|
|||||
Inventories,
net
|
67,577
|
60,738
|
|||||
Prepaid
expenses and other current assets
|
14,562
|
14,433
|
|||||
Deferred
compensation
|
2,795
|
-
|
|||||
Total
current assets
|
237,863
|
213,501
|
|||||
Property,
plant and equipment, net
|
62,349
|
62,287
|
|||||
Goodwill
|
43,300
|
43,789
|
|||||
Other
intangible assets, net
|
6,873
|
7,873
|
|||||
Investments
in associated companies
|
8,027
|
7,323
|
|||||
Deferred
income taxes
|
31,542
|
30,257
|
|||||
Other
assets
|
35,275
|
34,019
|
|||||
Total
assets
|
$
|
425,229
|
$
|
399,049
|
|||
LIABILITIES
AND SHAREHOLDERS' EQUITY
|
|||||||
Current
liabilities
|
|||||||
Short-term
borrowings and current portion of long-term debt
|
$
|
2,635
|
$
|
4,288
|
|||
Accounts
and other payables
|
71,196
|
67,380
|
|||||
Accrued
compensation
|
14,034
|
17,287
|
|||||
Deferred
compensation
|
3,006
|
-
|
|||||
Other
current liabilities
|
17,501
|
17,396
|
|||||
Total
current liabilities
|
108,372
|
106,351
|
|||||
Long-term
debt
|
85,364
|
78,487
|
|||||
Deferred
income taxes
|
8,217
|
7,583
|
|||||
Other
non-current liabilities
|
68,294
|
71,722
|
|||||
Total
liabilities
|
270,247
|
264,143
|
|||||
Minority
interest in equity of subsidiaries
|
4,339
|
4,513
|
|||||
Shareholders'
equity
|
|||||||
Common
stock, $1 par value; authorized 30,000,000 shares; issued 10,832,828
shares
|
10,833
|
10,147
|
|||||
Capital
in excess of par value
|
27,034
|
10,104
|
|||||
Retained
earnings
|
122,320
|
115,767
|
|||||
Accumulated
other comprehensive loss
|
(9,544
|
)
|
(5,625
|
)
|
|||
Total
shareholders' equity
|
150,643
|
130,393
|
|||||
Total
liabilities and shareholders' equity
|
$
|
425,229
|
$
|
399,049
|
(Unaudited)
|
|||||||
2008
|
2007
|
||||||
Cash
flows from operating activities
|
|||||||
Net
income
|
$
|
13,854
|
$
|
10,848
|
|||
Adjustments
to reconcile net income to net cash provided by operating activities:
|
|||||||
Depreciation
|
8,279
|
8,579
|
|||||
Amortization
|
906
|
900
|
|||||
Equity
in net income of associated companies, net of dividends
|
(490
|
)
|
(83
|
)
|
|||
Minority
interest in earnings of subsidiaries
|
841
|
1,126
|
|||||
Deferred
compensation and other, net
|
840
|
(620
|
)
|
||||
Stock-based
compensation
|
3,642
|
863
|
|||||
Environmental
charges
|
-
|
3,300
|
|||||
(Gain)
loss on disposal of property, plant and equipment
|
(3
|
)
|
33
|
||||
Insurance
settlement realized
|
(981
|
)
|
(1,266
|
)
|
|||
Pension
and other postretirement benefits
|
(3,541
|
)
|
(2,532
|
)
|
|||
Increase
(decrease) in cash from changes in current assets and current liabilities,
net of acquisitions:
|
|||||||
Accounts
receivable
|
(3,723
|
)
|
(5,795
|
)
|
|||
Inventories
|
(8,550
|
)
|
(3,227
|
)
|
|||
Prepaid
expenses and other current assets
|
(863
|
)
|
(1,750
|
)
|
|||
Accounts
payable and accrued liabilities
|
788
|
6,009
|
|||||
Net
cash provided by operating activities
|
10,999
|
16,385
|
|||||
Cash
flows from investing activities
|
|||||||
Capital
expenditures
|
(9,198
|
)
|
(5,431
|
)
|
|||
Payments
related to acquisitions
|
(1,000
|
)
|
(1,543
|
)
|
|||
Proceeds
from disposition of assets
|
139
|
176
|
|||||
Insurance
settlement received and interest earned
|
5,234
|
5,534
|
|||||
Change
in restricted cash, net
|
(13,578
|
)
|
(4,268
|
)
|
|||
Net
cash used in investing activities
|
(18,403
|
)
|
(5,532
|
)
|
|||
Cash
flows from financing activities
|
|||||||
Short-term
debt borrowings
|
-
|
1,305
|
|||||
Net
decrease in short-term borrowings
|
(1,389
|
)
|
(3,267
|
)
|
|||
Proceeds
from long-term debt
|
10,000
|
3,132
|
|||||
Repayments
of long-term debt
|
(3,165
|
)
|
(674
|
)
|
|||
Dividends
paid
|
(6,994
|
)
|
(6,484
|
)
|
|||
Stock
options exercised, other
|
13,974
|
2,935
|
|||||
Distributions
to minority shareholders
|
(252
|
)
|
(864
|
)
|
|||
Net
cash provided by (used in) financing activities
|
12,174
|
(3,917
|
)
|
||||
Effect
of exchange rate changes on cash
|
(899
|
)
|
1,226
|
||||
Net
increase in cash and cash equivalents
|
3,871
|
8,162
|
|||||
Cash
and cash equivalents at the beginning of the period
|
20,195
|
16,062
|
|||||
Cash
and cash equivalents at the end of the period
|
$
|
24,066
|
$
|
24,224
|